HIV health literacy is essential for people living with HIV (PLWH) to be able to navigate all of the information available, from testing and diagnosis to treatment options and outcomes. This series of webisodes seeks to promote patient education, focusing on the needs of diverse populations of PLWH, to empower learners and improve their understanding and HIV health literacy.
The American Geriatrics Society (AGS) Beers Criteria for Potentially Inappropriate Medications (PIM) Use in Older Adults has been an important resource for clinicians since 2011. In the 2023 edition, the expert panel provided key updates for anticoagulation in cardiovascular disease. This handy pocket card summarizes these recommendations.
Direct Oral Anticoagulants (DOACs) have come of age and are proving to be an efficacious and convenient means to provide anticoagulation for many patients with NVAF and/or VTE. However, striking the right balance between anticoagulation and bleeding risk is paramount, especially for patients with chronic kidney disease. This resource, adapted from the KDIGO (Kidney Disease Improving Global Outcomes) guidelines, provides a quick reference to warfarin and DOAC dosing, including adjustments for creatinine clearance (CrCl) in patients with various levels of renal insufficiency.
When implementing anticoagulants to prevent thrombotic events (eg, stroke, pulmonary embolism, deep vein thrombosis) in non-valvular atrial fibrillation (NVAF) and/or venous thromboembolism (VTE), it is critical to balance efficacy with bleeding risk. For patients who require anticoagulation and also have renal impairment, careful risk assessment is important. Not all bleeding risk calculators include renal considerations. This tool provides those that do, with links to both online and mobile app versions.
For many medical disciplines, shared decision making (SDM) is a keystone in contemporary clinician-patient communications. With an expanding menu of available anticoagulation options, including direct oral anticoagulants (DOACs), SDM takes on even greater importance in counseling patients with NVAF and/or VTE. This 1-page resource outlines the SHARE approach to SDM, along with suggested conversation starters to keep your patients engaged and adherent to therapies.
